This means that Orion's greenhouse gas (GHG) emissions reduction targets align with the latest climate science to limit global warming to 1.5 °C above pre-industrial levels.
Orion Corporation commits
- to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2023 base year
- that 78% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by 2029.
Scopes 1 and 2 refer to direct GHG emissions from our own operations and indirect emissions associated with the purchase of energy, respectively. These targets do not include carbon offsets.
“Industry must be at the forefront of tackling climate change,” says Liisa Hurme, President and CEO of Orion.
“As an innovative pharmaceutical company, science is at the heart of everything we do, so it was important for Orion to confirm that our near-term emissions reduction targets also align with the latest climate science."
"This approval is a significant step forward in our systematic sustainability work, and it reflects our purpose of building well-being.”
Concrete measures for a more sustainable future
To attain these targets, Orion will continue to implement a range of measures, including energy efficiency projects at our production sites.
We have made significant strides in improving energy efficiency, with projects that led to 11,459 MWh energy savings in 2023.
For example, our manufacturing plants in Turku and Espoo have implemented innovative heat pump systems that utilize waste heat and energy from outdoor air, significantly reducing our carbon footprint.
Our commitment extends beyond our own operations, as we work closely with suppliers and partners to reduce emissions throughout our value chain.
